BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26447062)

  • 1. Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.
    Vercellino M; Fenoglio C; Galimberti D; Mattioda A; Chiavazza C; Binello E; Pinessi L; Giobbe D; Scarpini E; Cavalla P
    Mult Scler; 2016 Jul; 22(8):1007-12. PubMed ID: 26447062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serum progranulin level might be associated with Parkinson's disease risk.
    Mateo I; González-Aramburu I; Pozueta A; Vázquez-Higuera JL; Rodríguez-Rodríguez E; Sánchez-Juan P; Calero M; Dobato JL; Infante J; Berciano J; Combarros O
    Eur J Neurol; 2013 Dec; 20(12):1571-3. PubMed ID: 23398167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
    Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.
    Ingram G; Hakobyan S; Hirst CL; Harris CL; Pickersgill TP; Cossburn MD; Loveless S; Robertson NP; Morgan BP
    Brain; 2010 Jun; 133(Pt 6):1602-11. PubMed ID: 20421219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
    Fenoglio C; Ridolfi E; Cantoni C; De Riz M; Bonsi R; Serpente M; Villa C; Pietroboni AM; Naismith RT; Alvarez E; Parks BJ; Bresolin N; Cross AH; Piccio LM; Galimberti D; Scarpini E
    Mult Scler; 2013 Dec; 19(14):1938-42. PubMed ID: 24277735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Dwyer DE; Taylor J; Blizzard L; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
    Mult Scler; 2012 Jun; 18(6):799-806. PubMed ID: 22084489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation.
    Strange RC; Ramachandran S; Zeegers MP; Emes RD; Abraham R; Raveendran V; Boggild M; Gilford J; Hawkins CP
    Mult Scler; 2010 Sep; 16(9):1109-16. PubMed ID: 20670983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males.
    Fenoglio C; Scalabrini D; Esposito F; Comi C; Cavalla P; De Riz M; Martinelli V; Piccio LM; Venturelli E; Fumagalli G; Capra R; Collimedaglia L; Ghezzi A; Rodegher ME; Vercellino M; Leone M; Giordana MT; Bresolin N; Monaco F; Comi G; Scarpini E; Martinelli-Boneschi F; Galimberti D
    Genes Immun; 2010 Sep; 11(6):497-503. PubMed ID: 20463744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder.
    Galimberti D; Prunas C; Paoli RA; Dell'Osso B; Fenoglio C; Villa C; Palazzo C; Cigliobianco M; Camuri G; Serpente M; Scarpini E; Altamura AC
    Bipolar Disord; 2014 Nov; 16(7):769-72. PubMed ID: 24499389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
    Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
    Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.
    Rossi S; Studer V; Moscatelli A; Motta C; Coghe G; Fenu G; Caillier S; Buttari F; Mori F; Barbieri F; Castelli M; De Chiara V; Monteleone F; Mancino R; Bernardi G; Baranzini SE; Marrosu MG; Oksenberg JR; Centonze D
    PLoS One; 2013; 8(6):e67357. PubMed ID: 23840674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
    Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between multiple sclerosis risk-associated SNPs and relapse and disability--a prospective cohort study.
    Lin R; Taylor BV; Simpson S; Charlesworth J; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
    Mult Scler; 2014 Mar; 20(3):313-21. PubMed ID: 23886828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis.
    Wilczak N; Ramsaransing GS; Mostert J; Chesik D; De Keyser J
    Mult Scler; 2005 Feb; 11(1):13-5. PubMed ID: 15732261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
    Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
    J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pentosidine: a potential biomarker in the management of multiple sclerosis.
    Sternberg Z; Hennies C; Sternberg D; Bistulfi GL; Kazim L; Benedict RH; Chadha K; Leung C; Weinstock-Guttman B; Munschauer F
    Mult Scler; 2011 Feb; 17(2):157-63. PubMed ID: 20965962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis.
    Kümpfel T; Gerdes LA; Wacker T; Blaschek A; Havla J; Krumbholz M; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Mult Scler; 2012 Sep; 18(9):1229-38. PubMed ID: 22337722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.
    Fenoglio C; Galimberti D; Cortini F; Kauwe JS; Cruchaga C; Venturelli E; Villa C; Serpente M; Scalabrini D; Mayo K; Piccio LM; Clerici F; Albani D; Mariani C; Forloni G; Bresolin N; Goate AM; Scarpini E
    J Alzheimers Dis; 2009; 18(3):603-12. PubMed ID: 19625741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.